Christopher Granger, MD: Antithrombotic Therapy in Patients with Atrial Fibrillation

Video

Growing evidence shows promise of stroke prevention with anti-thrombotic therapy in patients with AF.

In an interview with HCPLive®, Christopher Granger, MD, Duke University School of Medicine, spoke on the growing evidence around the use of anti-thrombotic therapy across cardiovascular disease.

Granger recently took part in an HCPLive® State of the Science "Institutional Perspectives in Cardiology: Cardiovascular Risk Management" event, chaired by Manesh Patel, MD, Duke University School of Medicine.

He presented a talk titled "Atrial Fibrillation: What Have We Learned About NOACs in Special Populations?"

"We've learned so much over the past 10 years about improving Stroke Prevention through anti thrombotic therapy for atrial fibrillation," Granger said. "And I think there are some really important recent observations that can help clinicians better apply the evidence better treat their patients with atrial fibrillation, with anti thrombotic therapy."

He noted his talk included a discussion on the undertreatment of AF, safety barriers and the need for further research on mechanical valves in treatment, patients with renal impairment, and patients with coronary stents and AF.

Related Videos
Video 2 - "Lessons from EXPLORER-HCM: Unveiling CMIs' Potential in oHCM Treatment "
Video 1 - "Novel Cardio Myosin Inhibitors Targeting Obstructive Hypertrophic Cardiomyopathy's Root Cause "
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
Heart Failure Treatment Outcomes and Contraindications
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
What Should the American Academy of Physician Associates Focus on in 2025?
The Rising Rate of Heat-Related Illness, with Janelle Bludhorn, PA-C
© 2024 MJH Life Sciences

All rights reserved.